← Leaderboards
Xuewu Liu
Methodist Hospital Research Institute
$2,224,398
Attributed
$5,128,763
Total exposure
4
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1M · FY2016–24$2M$1.5M$1M$500K$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$5,128,763 · 4
By mechanism
R01$2,488,179 · 2
U01$2,261,569 · 1
R21$379,015 · 1
Top collaborators
- Alessandro Grattoni4 shared
- Milos Kojic4 shared
- Fransisca Leonard3 shared
- Shu-Hsia Chen2 shared
- Junhua Mai2 shared
- Kenji Yokoi1 shared
Most similar at Methodist Hospital Research Institute
Same institution · by research overlap
- Alessandro Grattoni$14,325,435
- Keith Syson Chan$11,391,028
- Dan Theodorescu$43,145,134
- Milos Kojic$935,725
- Junhua Mai$789,361
Others in their field
Top investigators on “Biological”
- David Heimbrook · Leidos Biomedical Research, Inc.$731,505,112
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Lawrence Corey · Fred Hutchinson Cancer Center$543,202,300
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$480,487,534
- Tracy L Nolen · Research Triangle Institute$474,487,152
Research focus
BiologicalIn VitroResponseIn VivoCancer CellMalignant NeoplasmsBasePharmaceutical PreparationsPlayInnovationResistanceNanoparticleClinicTumorOncologyBlood PlateletsOrganTumor GrowthFutureModificationCell LineAffectSiteProteins
Grant awards (12)
Biophysical roles of pre-metastatic niche evolution on transport of circulating tumor cells$507,540
U01 · FY2024 · CA · contact PI
Biophysical roles of pre-metastatic niche evolution on transport of circulating tumor cells$523,568
U01 · FY2023 · CA · contact PI
Mechanism of Intratumoral Transport of Particulate Drugs$456,480
R01 · FY2023 · CA
Biophysical roles of pre-metastatic niche evolution on transport of circulating tumor cells$526,195
U01 · FY2022 · CA · contact PI
Mechanism of Intratumoral Transport of Particulate Drugs$458,897
R01 · FY2022 · CA
Biophysical roles of pre-metastatic niche evolution on transport of circulating tumor cells$704,266
U01 · FY2021 · CA
A nanofluidic platform for tunable drug delivery$338,921
R01 · FY2021 · GM
A nanofluidic platform for tunable drug delivery$395,723
R01 · FY2020 · GM
A nanofluidic platform for tunable drug delivery$412,720
R01 · FY2019 · GM
A nanofluidic platform for tunable drug delivery$425,438
R01 · FY2018 · GM
Exosome analysis of drug-resistant cancer cells' response to nanoparticle therapy$173,456
R21 · FY2017 · CA · contact PI
Exosome analysis of drug-resistant cancer cells' response to nanoparticle therapy$205,559
R21 · FY2016 · CA · contact PI